Enko® designs safe and sustainable solutions to farmers’ biggest crop threats, from pest resistance to new diseases. By applying the latest drug discovery and development approaches from pharma to plants, Enko is bringing an innovation model to agriculture and meeting farmers’ evolving needs. Founded in 2017 and led by a team of proven scientists, entrepreneurs and agriculture industry veterans, Enko is backed by investors including the Bill & Melinda Gates Foundation, Anterra Capital, Finistere Ventures, Novalis LifeSciences, Germin8 Ventures, TO Ventures Food, and Rabo Food & Agri Innovation Fund.
Looking for a particular Enko® employee's phone or email?
The Enko® annual revenue was $11.6 million in 2026.
Anthony Klemm is the CEO of Enko®.
63 people are employed at Enko®.
The NAICS codes for Enko® are [111, 32, 325, 11].
The SIC codes for Enko® are [287, 1, 28].